Apremilast (Compound)

Synonyms:Apremilast, 608141-41-9, CC-10004, OTEZLA, CC 10004, Apremilast (CC-10004), CC10004, CHEBI:78540, (S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide, UP7QBP99PN, CHEMBL514800, N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide, C22H24N2O7S, (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide, N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide, (+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo- 2,3-dihydro-1H-isoindol-4-yl)acetamide, Apremilast [USAN], Apremilast [USAN:INN], UNII-UP7QBP99PN, apremilastum, MFCD18782607, HSDB 8221, Apremilast- Bio-X, Otezla (TN), APREMILAST [MI], APREMILAST [INN], APREMILAST [JAN], Apremilast (JAN/USAN), APREMILAST [VANDF], APREMILAST [WHO-DD], SCHEMBL302992, AMY371, GTPL7372, APREMILAST [ORANGE BOOK], DTXSID30976289, EX-A336, cas:608141-41-9;Apremilast, BCP03783, BCP25283, BDBM50248919, s8034, AKOS016339660, BCP9000311, CCG-269336, CS-0671, DB05676, FK-0727, AC-27650, BA164215, HY-12085, BCP0726000109, SW219856-1, D08860, EN300-7423712, Q2858961, Z1837762189, (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione(Apremilast), (S)-N-{2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}-acetamide, 4-[[5 pound not7-dihydroxy-2 pound not2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methy l]-3 pound not5-dihydroxy-6 pound not6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2 pound not4-dien- 1-one, A9L, Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-, Acetamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-, N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide

Pubchem:PUBCHEM:11561674

Id:9cbd61d3-7e27-5089-908d-072a4e036f24

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Apremilast's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Apremilast.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Apremilast.

Results found

Linked to

	Label	Description
	BRD-K93208532-001-02-5 Substance (Entity type)	A Substance
	DCSTRUCT ID 04829 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04829; PubChem_CID:11561674, FILE=drugcentral_drug_04829.json)
	apremilast (49cda776-6a60-4af1-850e-d8779669122b) Collection (Entity type)	Metadatata for apremilast
	Apremilast positively regulates CITED2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Apremilast negatively regulates EREG Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Apremilast bioactivity cAMP-specific 3',5'-cyclic phosphodiesterase 4C Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Apremilast negatively regulates S100A8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Apremilast negatively regulates PLAC8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Apremilast positively regulates PCNA Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Apremilast bioactivity cAMP-specific 3',5'-cyclic phosphodiesterase 4A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG